Literature DB >> 25824938

T-lymphocyte phenotype and function triggered by Aggregatibacter actinomycetemcomitans is serotype-dependent.

J Díaz-Zúñiga1,2, S Melgar-Rodríguez1,2, C Alvarez1, G Monasterio1, A Benítez1, P Ciuchi1, C Díaz2, J Mardones2, A Escobar3, M Sanz4, R Vernal1,2.   

Abstract

BACKGROUND AND
OBJECTIVE: Based on lipopolysaccharide (LPS) antigenicity, different Aggregatibacter actinomycetemcomitans serotypes have been described. Serotype b strains have demonstrated a stronger capacity to trigger cytokine production on dendritic cells (DCs). As DCs regulate the development of T-lymphocyte lineages, the objective of this investigation was to study the response of T lymphocytes after being stimulated with autologous DCs primed with different bacterial strains belonging to the most prevalent serotypes of A. actinomycetemcomitans in humans: a-c.
MATERIAL AND METHODS: Human DCs were primed with increasing multiplicity of infection (10(-1) -10(2) ) or the purified LPS (10-50 ng/mL) of A. actinomycetemcomitans serotypes a-c and then used to stimulate autologous naïve CD4(+) T lymphocytes. The T-helper (Th) type 1, Th2, Th17 and T-regulatory transcription factors T-bet, GATA-3, RORC2 and Foxp3, which are the master-switch genes implied in their specific differentiation, as well as T-cell phenotype-specific cytokine patterns were quantified by real-time reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay. In addition, the intracellular expression of T-bet/interferon-γ, GATA-3/interleukin-4, RORC2/interleukin-17A and Foxp3/transforming growth factor-β1 was analysed by double staining and flow cytometry.
RESULTS: All the A. actinomycetemcomitans serotypes led to T-lymphocyte activation; however, when T lymphocytes were stimulated with DCs primed with the A. actinomycetemcomitans serotype b strain or their purified LPS, higher levels of Th1- and Th17-associated transcription factors and cytokines were detected compared with similar experiments with the other serotypes.
CONCLUSION: These results demonstrate that serotype b of A. actinomycetemcomitans has a higher capacity of trigger Th1 and Th17 phenotype and function and it was demonstrated that their LPS is a more potent immunogen compared with the other serotypes.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Aggregatibacter actinomycetemcomitans; T lymphocytes; cytokines; lipopolysaccharide; serotypes; transcription factors

Mesh:

Substances:

Year:  2015        PMID: 25824938     DOI: 10.1111/jre.12270

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  14 in total

1.  Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4+ T lymphocytes.

Authors:  Francisca Castillo; Gustavo Monasterio; Juan Pablo Ibarra; José Guevara; Emilio A Cafferata; Emiliano Vicencio; Cristian Cortez; Paola Carvajal; Rolando Vernal
Journal:  Clin Oral Investig       Date:  2021-02-05       Impact factor: 3.573

Review 2.  Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis.

Authors:  B A Herbert; C M Novince; K L Kirkwood
Journal:  Mol Oral Microbiol       Date:  2015-09-22       Impact factor: 3.563

3.  Functional Haplotypes in Interleukin 4 Gene Associated with Periodontitis.

Authors:  Giovana Anovazzi; Marcell Costa de Medeiros; Suzane Cristina Pigossi; Livia Sertori Finoti; Marcia Pinto Alves Mayer; Carlos Rossa; Raquel Mantuaneli Scarel-Caminaga
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

4.  Aggregatibacter Actinomycetemcomitans Induces Autophagy in Human Junctional Epithelium Keratinocytes.

Authors:  Emiliano Vicencio; Esteban M Cordero; Bastián I Cortés; Sebastián Palominos; Pedro Parra; Tania Mella; Constanza Henrríquez; Nelda Salazar; Gustavo Monasterio; Emilio A Cafferata; Paola Murgas; Rolando Vernal; Cristian Cortez
Journal:  Cells       Date:  2020-05-14       Impact factor: 6.600

Review 5.  Virulence and Pathogenicity Properties of Aggregatibacter actinomycetemcomitans.

Authors:  Georgios N Belibasakis; Terhi Maula; Kai Bao; Mark Lindholm; Nagihan Bostanci; Jan Oscarsson; Riikka Ihalin; Anders Johansson
Journal:  Pathogens       Date:  2019-11-06

6.  Premature Senescence of T-cells Favors Bone Loss During Osteolytic Diseases. A New Concern in the Osteoimmunology Arena.

Authors:  Luis González-Osuna; Alfredo Sierra-Cristancho; Carolina Rojas; Emilio A Cafferata; Samanta Melgar-Rodríguez; Angélica M Cárdenas; Rolando Vernal
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 7.  Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies.

Authors:  Carolina Rojas; Michelle P García; Alan F Polanco; Luis González-Osuna; Alfredo Sierra-Cristancho; Samanta Melgar-Rodríguez; Emilio A Cafferata; Rolando Vernal
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

8.  Differential expression of CC chemokines (CCLs) and receptors (CCRs) by human T lymphocytes in response to different Aggregatibacter actinomycetemcomitans serotypes.

Authors:  Carla Alvarez; Alvaro Benítez; Leticia Rojas; Myriam Pujol; Paola Carvajal; Jaime Díaz-Zúñiga; Rolando Vernal
Journal:  J Appl Oral Sci       Date:  2015 Nov-Dec       Impact factor: 2.698

9.  Differential expression of CC chemokines (CCLs) and receptors (CCRs) by human T lymphocytes in response to different Aggregatibacter actinomycetemcomitans serotypes.

Authors:  Carla Alvarez; Alvaro Benítez; Leticia Rojas; Myriam Pujol; Paola Carvajal; Jaime Díaz-Zúñiga; Rolando Vernal
Journal:  J Appl Oral Sci       Date:  2015-10       Impact factor: 2.698

10.  Rheumatoid Arthritis-Associated Autoimmunity Due to Aggregatibacter actinomycetemcomitans and Its Resolution With Antibiotic Therapy.

Authors:  Amarshi Mukherjee; Vanessa Jantsch; Rida Khan; Wolfgang Hartung; René Fischer; Jonathan Jantsch; Boris Ehrenstein; Maximilian F Konig; Felipe Andrade
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.